Advertisement

Related Videos

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Amit Sanyal, MD: A Clinician’s Perspective

Advertisement

Advertisement




Sep
30
Today In Oncology
Cleveland Clinic to Host Second Annual AI Summit for Health-Care Professionals
Cleveland Clinic President Discusses AI Summit for Health-Care Professionals
AI’s Evolving Role in Clinical Care Enterprise-Wide
Long-Term Disease Control From SBRT Equal to Surgery in Localized Prostate Cancer
Cancer Statistics 2026: What Every Medical Oncologist Should Know
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo